PointState Capital’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

PointState Capital’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-81,400	Closed	-$3.04M	–	214
2018 Q1	$3.04M	Buy	+81,400	New	+$3.42M	0.03%	128

PointState Capital's ARMO Position: Q2 2018 in Review

PointState Capital sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 81,400 shares — an estimated $3.04M sold.

PointState Capital first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $3.04M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

PointState Capital reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
PointState Capital sold 81,400 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $3.04M.
PointState Capital first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
PointState Capital's ARMO BioSciences, Inc. Common Stock position peaked at $3.04M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on PointState Capital's 13F filing for Q2 2018, filed 14 Aug 2018.